Items where authors include "Bernardo, M"

Article

Dorison, CA, Lerner, JS, Heller, BH et al. (475 more authors) (2022) In COVID-19 health messaging, loss framing increases anxiety with little-to-no concomitant benefits: experimental evidence from 84 countries. Affective Science, 3 (3). pp. 577-602. ISSN 2662-205X

Ferraro, L, Quattrone, D, La Barbera, D et al. (33 more authors) (2022) First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data. Schizophrenia Bulletin. sbac100. ISSN 0586-7614

Legate, N, Ngyuen, T-V, Weinstein, N et al. (552 more authors) (2022) A global experiment on motivating social distancing during the COVID-19 pandemic. Proceedings of the National Academy of Sciences, 119 (22). e2111091119. ISSN 0027-8424

Ferraro, L, La Cascia, C, La Barbera, D et al. (39 more authors) (2021) The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study. Schizophrenia research, 236. pp. 69-79. ISSN 0920-9964

Quattrone, D, Reininghaus, U, Richards, AL et al. (42 more authors) (2021) The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study. Translational Psychiatry, 11. 423. ISSN 2158-3188

Wang, K, Goldenberg, A, Dorison, CA et al. (453 more authors) (2021) A multi-country test of brief reappraisal interventions on emotions during the COVID-19 pandemic. Nature Human Behaviour, 5 (8). pp. 1089-1110. ISSN 2397-3374

Quattrone, D, Ferraro, L, Tripoli, G et al. (39 more authors) (2020) Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case–control study. Psychological Medicine. ISSN 0033-2917